A survey on adherence to secondary ischemic stroke prevention

被引:38
作者
Wang, YJ
Wu, D
Wang, YL
Ma, RH
Wang, CX
Zhao, WK
机构
[1] Capital Univ Med Sci, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China
[2] Capital Univ Med Sci, Grad Sch, Beijing 100054, Peoples R China
关键词
antithrombotic therapy; medical treatment; ischemic stroke;
D O I
10.1179/016164106X91816
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Reduced adherence and compliance to discharge instructions and protocols could significantly influence the ability of any stroke prevention strategy. The goals of this investigation were to evaluate the adherence to secondary prevention strategies within 1 year after ischemic stroke and to identify possible causes of poor compliance with these strategies. Patients who had suffered either acute ischemic stroke or transient ischemic attacks (TIA) were recruited retrospectively through telephone follow-up. The survey included whether the patient was prescribed antithrombotic treatment at discharge and reasons for non-compliance with this prescription both immediately after discharge and 1 year after discharge. Of 472 (73.8%) patients with detailed clinical data who were finally evaluated in this survey, 326 (69.1%) were still under antithrombotic treatment and 172 (36.4%) underwent the same antithrombotic agent as prescribed when discharged. We found that medical insurance and free medical care were able to promote compliance with medication in stroke patients for secondary prevention, while administration of non-aspirin antithrombotic agents or a poor ability for daily activities (Barthel index, BI) had significantly negative effects on medication compliance in stroke patients. Under the conditions of this observational study, adherence to stroke prevention strategies was poor. Income levels, categories of antithrombotic agents and the personal living ability are closely related to compliance. The results suggest that doctors should pay more attention to the secondary prevention of stroke. We suggest that providing stroke patients with detailed instructions for medication usage, physicians could increase the potential that their secondary prevention of stroke could be increased.
引用
收藏
页码:16 / 20
页数:5
相关论文
共 16 条
  • [1] [Anonymous], 2001, CIRCULATION, V104, P2118
  • [2] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [3] Blackshear JL, 1996, LANCET, V348, P633
  • [4] Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
    Diener, HC
    Bogousslavsky, J
    Brass, LM
    Cimminiello, C
    Csiba, L
    Kaste, M
    Leys, D
    Matias-Guiv, J
    Rupprecht, HJ
    [J]. LANCET, 2004, 364 (9431) : 331 - 337
  • [5] Attrition and non-compliance in secondary stroke prevention trials
    Gencheva, E
    Sloan, M
    Leurgans, S
    Raman, R
    Harris, Y
    Gorelick, P
    [J]. NEUROEPIDEMIOLOGY, 2004, 23 (1-2) : 61 - 66
  • [6] Adherence to secondary stroke prevention strategies - Results from the German stroke data bank
    Hamann, GF
    Weimar, C
    Glahn, J
    Busse, O
    Diener, HC
    [J]. CEREBROVASCULAR DISEASES, 2003, 15 (04) : 282 - 288
  • [7] Haynes R B, 2002, Cochrane Database Syst Rev, pCD000011
  • [8] Antithrombotic and antihypertensive management 3 months after ischemic stroke - A prospective study in an inner city population
    Hillen, T
    Dundas, R
    Lawrence, E
    Stewart, JA
    Rudd, AG
    Wolfe, CDA
    [J]. STROKE, 2000, 31 (02) : 469 - 475
  • [9] Stroke prevention - Narrowing the evidence-practice gap
    Holloway, RG
    Benesch, C
    Rush, SR
    [J]. NEUROLOGY, 2000, 54 (10) : 1899 - 1906
  • [10] A metaregression analysis of the dose-response effect of aspirin on stroke
    Johnson, ES
    Lanes, SF
    Wentworth, CE
    Satterfield, MH
    Abebe, BL
    Dicker, LW
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (11) : 1248 - 1253